RPG Life Sciences Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares RPG Life Sciences Limited with three other
companies in this sector in India:
Kopran Limited
(2019
sales of 3.58 billion Indian Rupees [US$50.32 million]
of which 48%
was Bulk Drugs),
Amrutanjan Health Care Limited
(2.53 billion Indian Rupees [US$35.60 million]
of which 91%
was OTC Products), and
Albert David Limited
(3.17 billion Indian Rupees [US$44.55 million]
).
Sales Analysis.
RPG Life Sciences Limited reported sales of 3.30 billion Indian Rupees (US$46.42 million)
for the
fiscal
year ending
March of 2019.
This
represents
a
decrease of 4.0%
versus 2018, when the company's sales were 3.44 billion Indian Rupees.